MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Pexels Alexander Suhorucov

Plain Language Summary Development in Japan: Current State and Challenges

This page contains supplementary information to support a poster presented at the Virtual 17th Annual...
AI in Research

Artificial Intelligence Is Democratizing Research and There’s More to Come

Today AI technologies are employed to both create and consume research. Scientists across the world...
Counting on AI: The right time for researchers and pharma

Counting on AI: The Right Time for Researchers and Pharma to Embrace Artificial Intelligence

The right AI–powered tools and techniques can make a significant difference in how research is...
Trends in publication review of articles

Review Article Publication Trends

This poster was presented by representatives from Cactus Life Sciences at the 11th Annual Meeting...
International publication guidelines in Asia

Awareness of International Publication Guidelines in Asia

This poster presents the results of an analysis of how familiar Asian authors are with...
Medical writing and communication during the COVID-19 crisis

Medical Writing and Medical Communication during COVID-19 Crisis: AMWA Virtual Event

How medical writers and science communicators are called to respond to the COVID-19 infodemic...

Learn more ABOUT our company.